Home › Metastatic Cancer › NCT06081517
Evaluating Disparities in Precision Oncology
RecruitingObservational study
Evaluating Disparities in Precision Oncology: An Observational Trial in the Context of a Real-World Academic Practice Model
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: 1. Ability to provide written informed consent and HIPAA authorization 2. Patients must be ≥ 18 years old at the time of consent 3. Patients who have or are planning to undergo molecular testing as part of their routine cancer care Exclusion Criteria: N/A
About the study
This is a non-randomized observational trial designed to collect detailed clinical, social determinant, and genomic data from patients enrolled in molecular oncology tumor boards across four comprehensive cancer centers.
What is being tested
- Social Determinants of Health and toxicity questionnaires (behavioral)
Sponsor: Indiana University · Participants: 10,600 · Started: Jan 26, 2024
Contact the study team
- Maria McQuade, BA · Phone: (317) 278-5238
- Bryan P Schneider, MD · Phone: 317-948-3855
Official record on ClinicalTrials.gov — NCT06081517
Locations in the U.S.
| Indiana | Indiana University Health Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis |
Conditions
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.